Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000621384 | SCV000735250 | benign | Cardiovascular phenotype | 2016-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001566981 | SCV001790582 | likely benign | not provided | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001566981 | SCV002492342 | benign | not provided | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003230557 | SCV003929124 | benign | not specified | 2023-04-09 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917977 | SCV004736552 | benign | TBX20-related disorder | 2024-01-19 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |